Takara Bio Inc. (FRA:TF2)

Takara Bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	537	616	716	1,445	2,000	2,753
Market Cap Growth	-30.50%	-13.94%	-50.46%	-27.77%	-27.34%	21.18%
Enterprise Value	478	441	501	1,232	1,740	2,586
Last Close Price	4.12	4.78	5.53	11.25	15.19	20.88
PE Ratio	-	95.78	78.92	13.03	13.60	37.44
PS Ratio	2.12	2.21	2.69	2.67	3.99	7.76
PB Ratio	0.91	0.86	1.05	1.86	2.81	4.81
P/TBV Ratio	1.19	0.93	1.13	2.02	3.11	5.52
P/FCF Ratio	-	-	-	6.70	-	68.00
P/OCF Ratio	33.43	17.06	68.27	5.66	38.63	25.63
EV/Sales Ratio	2.00	1.58	1.88	2.28	3.47	7.28
EV/EBITDA Ratio	19.95	10.57	10.19	7.04	7.10	18.92
EV/EBIT Ratio	-	31.51	27.22	8.66	8.12	24.06
EV/FCF Ratio	-4.53	-	-	5.71	-	63.86
Debt / Equity Ratio	0.10	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	2.27	0.16	0.12	0.04	0.03	0.06
Debt / FCF Ratio	-	-	-	0.03	-	0.22
Asset Turnover	0.34	0.37	0.35	0.64	0.66	0.56
Inventory Turnover	1.58	1.56	1.45	1.90	1.11	1.70
Quick Ratio	3.73	6.11	6.52	4.47	2.38	2.93
Current Ratio	5.50	8.09	8.76	5.40	3.92	3.72
Return on Equity (ROE)	-5.79%	0.95%	1.35%	15.39%	23.37%	13.60%
Return on Assets (ROA)	-0.24%	1.15%	1.50%	10.48%	17.58%	10.59%
Return on Capital (ROIC)	-0.27%	1.23%	1.66%	12.20%	20.94%	12.18%
Return on Capital Employed (ROCE)	-0.40%	1.90%	2.60%	17.90%	29.40%	18.20%
Earnings Yield	-6.85%	1.04%	1.27%	7.67%	7.36%	2.67%
FCF Yield	-19.67%	-4.04%	-9.47%	14.93%	-2.01%	1.47%
Dividend Yield	2.61%	2.20%	1.88%	2.58%	1.61%	0.59%
Payout Ratio	-	196.73%	341.35%	24.78%	9.69%	10.08%
Total Shareholder Return	2.61%	2.20%	1.88%	2.58%	1.61%	0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.